Showing results (21-30 of 70) with videos related to
Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2023
Development and Current State of Digital Therapeutics for Irritable Bowel SyndromeDarren M Brenner, Amy M Ladewski, Sarah Wimberly KinsingerThe American Journal of Gastroenterology|June 12, 2013
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysisAlexander C Ford, Darren M Brenner, Philip S SchoenfeldClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2021
Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical DataBrian E Lacy, Darren M Brenner, William D CheyThe American Journal of Gastroenterology|March 31, 2022
Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With ConstipationAmy Kassebaum-Ladewski, David M Poppers, Darren M BrennerThe American Journal of Gastroenterology|May 7, 2019
A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced ConstipationDarren M Brenner, Yiqun Hu, Catherine Datto, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 5, 2023
Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus DocumentDarren M Brenner, Maura Corsetti, Douglas Drossman, et al.Gut|May 7, 2018
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysisPavit Luthra, Nicholas E Burr, Darren M Brenner, et al.Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamideDarren M Brenner, Gregory S Sayuk, Jessica L Abel, et al.The American Journal of Gastroenterology|March 12, 2009
The utility of probiotics in the treatment of irritable bowel syndrome: a systematic reviewDarren M Brenner, Matthew J Moeller, William D Chey, et al.Behaviour Research and Therapy|April 13, 2013
Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndromeJeffrey M Lackner, Gregory D Gudleski, Jennifer Dimuro, et al.Pageof 7